Benazepril Market Report 2025 (Global Edition)

Global Benazepril Market Report 2025 Market Size Split by Formulation (Tablets, Capsules, Injectable), by Strength (Low Strength, Medium Strength, High Strength), by Application (Hypertension, Heart F...

Benazepril Market Report Description

We have various report editions of Benazepril Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Benazepril Market Insights Video

Competitive Landscape of the Benazepril Market

The market landscape of Benazepril is relatively competitive, with a generic and branded formulation. Larger numbers of manufacturers compete for market share with one and the same drug. Companies are highly focused on product differentiation by improving formulation and mechanism for enhanced delivery to attract the healthcare provider and the patient. Pricing strategy becomes important as generic versions of Benazepril are cost-effective alternatives that have enhanced competition.

Recent Development

In November 2022, Amneal Pharmaceuticals LLC established collaborations with a variety of healthcare professionals and pharmacy chains to expand the marketing of their Benazepril medicines. This strategic initiative attempts to boost patient access and market visibility for their offerings. (Source: https://investors.amneal.com/news/press-releases/press-release-details/2024/Amneal-Expands-Biosimilars-Portfolio-to-Eight-Products-with-Addition-of-Omalizumab-Biosimilar/default.aspx)

In February 2022, Sun Pharmaceutical Industries Ltd. has been investing in research and development to investigate new Benazepril formulations that may increase patient compliance and efficacy. These activities are part of a larger plan to develop in the cardiovascular drug area and meet the growing need for effective hypertension therapies. (Source: https://www.business-standard.com/companies/news/open-to-inorganic-opportunities-in-specialty-drugs-says-sun-pharma-124070800898_1.html)

In February 2022, Several businesses, including Teva Pharmaceutical Industries and Mylan N.V., have introduced generic versions of Benazepril in recent years. This has increased market competition, making drugs more accessible and affordable to patients. The introduction of generics is predicted to have a substantial impact on sales and market dynamics. (Source:https://www.justice.gov/opa/pr/major-generic-drug-companies-pay-over-quarter-billion-dollars-resolve-price-fixing-charges )

Top Companies Market Share in Benazepril Industry: (In no particular order of Rank)

• Amneal Pharmaceuticals LLC
• ANI Pharmaceuticals
• Inc.
• Apotex Inc
• Aurobindo Pharma
• Canagen Pharmaceuticals Inc
• Mylan N.V.
• ScinoPharm Taiwan
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Zydus Pharmaceuticals
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Benazepril Market

Which Region Dominates the Benazepril Market in 2024?

According to Cognitive Market Research, North America currently dominates the Benazeprils market, and the region is expected to have significant growth during the projected period. This is due to the rising prevalence of hypertension and cardiovascular diseases in the population has enhanced the need for efficacious antihypertensive drugs like Benazepril.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). Day-to-day awareness related to chronic diseases with the aspect of managing blood pressure prescription rates are continually increasing.

The current report Scope analyzes Benazepril Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Benazepril

According to Cognitive Market Research, the global Benazepril market size was estimated at USD 102514.2 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 57562.4 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Benazepril market with a market size of USD 32353.48 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. The U.S. market's growing focus on cardiovascular health.
• The Canada Benazepril market had a market share of USD 4920.68 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Canada’s ongoing research and development in combination therapies
• The Mexico Benazepril market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 3731.52 million in 2024.

Europe Benazepril

According to Cognitive Market Research, the global Benazepril market size was estimated at USD 102514.2 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 30754.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.0% from 2024 to 2031.

• The United Kingdom Benazepril market had a market share of USD 5166.72 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. In the UK, Benazepril sales witness an upswing due to the intervention and treatment options
• The France Benazepril market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 2829.39 million in 2024.
• According to Cognitive Market Research, the German Benazepril market size was valued at USD 6089.34 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. In Germany, Benazepril surged due to the availability of generic versions and insurance coverage .
• The Italy Benazepril market is projected to witness growth at a CAGR of 3.4% during the forecast period, with a market size of USD 2644.87 million in 2024.
• The Russia Benazepril market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 4766.91 million in 2024.
• The Spain Benazepril market is projected to witness growth at a CAGR of 3.1% during the forecast period with a market size of USD 2521.85 million in 2024
• The Luxembourg Benazepril market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 953.38 million in 2024.
• The Portugal Benazepril market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 645.84 million in 2024.
• The Greece Benazepril market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 369.05 million in 2024.
• The Rest of Europe's Benazepril market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 4766.91 million in 2024.

Asia Pacific Benazepril

According to Cognitive Market Research, the global Benazepril market size was estimated at USD 102514.2 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 23578.27 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Benazepril market size was valued at USD 10610.22 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Benazepril surged in China due to major market players.
• The Japan Benazepril market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 3253.80 million in 2024.
• The India Benazepril market had a market share of USD 2829.39 million in 2024 and is projected to grow at a CAGR of 9.3% during the forecast period. India's availability of both branded and generic options.
• The South Korean Benazepril market is projected to witness growth at a CAGR of 6.6% during the forecast period, with a market size of USD 2357.83 million in 2024.
• The Australian Benazepril market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 1226.07 million in 2024.
• The Southeast Asia Benazepril market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 1626.90 million in 2024.
• The Rest of Asia Pacific Benazepril market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 1674.06 million in 2024.

South America Benazepril

According to Cognitive Market Research, the global Benazepril market size was estimated at USD 102514.2 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 5125.7 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Benazepril market size was valued at USD 2193.80 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Benazepril flourished in Brazil due to increasing demand for packaged food and beverages.
• Argentina's Benazepril market had a market share of USD 861.12 million in 2024 and is projected to grow at a CAGR of 5.8% during the forecast period. Argentina's rising personal disposable income .
• Colombia Benazepril market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 456.19 million in 2024.
• Peru Benazepril market is projected to witness growth at a CAGR of 5.1% during the forecast period, with a market size of USD 420.31 million in 2024.
• Chile Benazepril market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 369.05 million in 2024.
• The Rest of Latin America's Benazepril market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 825.24 million in 2024.

Middle East Benazepril

According to Cognitive Market Research, the global Benazepril market size was estimated at USD 102514.2 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 2050.28 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031..

• The GCC Countries Benazepril market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 877.52 million in 2024. Benazepril sales flourish due to the presence of major market players.
• The Egypt Benazepril market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 215.28 million in 2024.
• The South Africa Benazepril market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 323.94 million in 2024. Benazepril sales flourished in South Africa due to the availability of affordable generic versions.
• The Turkey Benazepril market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 176.32 million in 2024.
• The Nigeria Benazepril market is projected to witness growth at a CAGR of 4.3% during the forecast period, with a market size of USD 215.28 million in 2024.
• The Rest of the MEA Benazepril market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 1.11 million in 2024.

Benazepril Market Analysis

Benazepril Market Formulation Segment Analysis

According to Cognitive Market Research, tablets now dominate the market because to their convenience of use, accurate dosing, and widespread availability. Tablets are the most commonly recommended form of Benazepril Hydrochloride, particularly in outpatient settings where convenience of administration and patient compliance are critical. The tablet category is likely to maintain its dominance during the forecast period, owing to ongoing improvements in tablet formulations that improve drug stability and absorption

Capsules are another important section of the Benazepril market. Although capsules are less common than tablets, they do provide some advantages, such as rapid disintegration and absorption, which can be useful in emergency medical conditions. The capsule segment is expanding steadily, owing to increased preference for this dosage form among certain patient groups and advances in capsule manufacturing technologies. Gel capsule formulations are increasingly gaining popularity, providing an alternative for patients who have difficulties swallowing regular tablets

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Benazepril Industry. Request a Free Sample PDF!

Benazepril Market Strength Segment Analysis

According to Cognitive Market Research, In the Benazepril market, the major share-of-this segment is mainly in the Medium Strength. Since the efficacy and tolerability are balanced, most patients with different stages of hypertension prefer it. Doctors prescribe medium strength strength formulations in order to reduce the chances of side effects and to be sure that patients will maintain controlled blood pressure.

The High Strength segment is progressing at the fastest rate. Growth in this segment can be attributed to the rising number of patients who require high-intensity management of their hypertension, especially those with comorbid conditions. With a growing awareness about cardiovascular health and more and more patients seeking effective treatments, demand for Benazepril high-strength dosage forms will only grow going forward.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Benazepril Application Segment Analysis

Benazepril Market Application Segment Analysis

According to Cognitive Market Research, Hypertension is the greatest application segment, owing to the significant occurrence of this illness worldwide. Benazepril , an ACE inhibitor, is extremely successful at lowering blood pressure and preventing hypertension-related problems. The growing emphasis on early detection and control of hypertension is likely to drive up demand for Benazepril Hydrochloride, making it an essential component of millions of patients' treatment regimens globally.

In the Benazepril market, the rapidly growing sector is Chronic kidney disease (CKD). Benazepril is finding use in the treatment of chronic kidney disease (CKD). The drug's potential to minimize proteinuria and halt the course of kidney damage make it an important treatment choice for CKD patients. The increased prevalence of diabetes and hypertension, both of which are major risk factors for CKD, will raise the demand for effective treatments. As a result, the chronic kidney disease market is expected to expand significantly throughout the forecast period

• Hypertension
• Heart Failure
• Kidney Disease
• Others (e.g.
• cardiovascular diseases)

Benazepril Distribution channel Segment Analysis

Benazepril Market Distribution channel Segment Analysis

According to Cognitive Market Research, Hospital pharmacies currently dominate the industry, accounting for a sizable part due to the huge amount of prescriptions written in hospital settings. Hospital pharmacies play an important role in the distribution of Benazepril Hydrochloride since they are frequently the initial point of contact for patients with hypertension and related illnesses.

Online pharmacies are a fast expanding delivery source for Benazepril. The convenience of online ordering, home delivery, and competitive price are bringing more patients to this channel. The COVID-19 epidemic has boosted the use of internet pharmacies, as patients want to limit their exposure to healthcare settings. The online pharmacies segment is expected to develop the quickest during the projected period, driven by increased internet access and acceptance of digital health platforms

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion